Article
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.
Alzheimer's research & therapy - 18 Mar 2022
Alegret Montserrat, Sotolongo-Grau Oscar, de Antonio Ester Esteban, Pérez-Cordón Alba, Orellana Adelina, Espinosa Ana, Gil Silvia, Jiménez Daniel, Ortega Gemma, Sanabria Angela, Roberto Natalia, Hernández Isabel, Rosende-Roca Maitee, Tartari Juan Pablo, Alarcon-Martin Emilio, de Rojas Itziar, Montrreal Laura, Morató Xavier, Cano Amanda, Rentz Dorene M, Tárraga Lluís, Ruiz Agustín, Valero Sergi, Marquié Marta, Boada Mercè
Abstract excerpt
BACKGROUND: FACEmemory® is the first computerized, self-administered verbal episodic memory test with voice recognition. It can be conducted under minimal supervision and contains an automatic scoring system to avoid administrator errors. Moreover, it is suitable for discriminating between cognitively healthy and amnestic mild cognitive impairment (MCI) individuals, and it is associated with Alzheimer's disease...
Topics
Join the communities discussing this publication.